Biotech Values : BMY raised 2011 non-GAAP EPS guidance to...

Biotech Values

Next 10 Prev Next

Send PM Follow Ignore

Re: DewDiligence post# 113621

Thursday, 07/28/2011 11:32:54 PM

Thursday, July 28, 2011 11:32:54 PM

BMY raised 2011 non-GAAP EPS guidance to $2.20-2.30 from the prior range of $2.08-2.18:

http://finance.yahoo.com/news/BristolMyers-Squibb-Delivers-bw-2995389373.html?x=0&.v=1

Non-GAAP EPS guidance for 2013 (first year post Plavix genericization) is unchanged at $1.95+ (#msg-47502391). There is no formal guidance for 2012.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.